XML 29 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
ACQUISITION (Details) (USD $)
 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 0 Months Ended 3 Months Ended
Sep. 29, 2012
Oct. 01, 2011
Sep. 29, 2012
Oct. 01, 2011
Sep. 29, 2012
Pall Corporation [Member]
Sep. 29, 2012
Pall Corporation [Member]
Oct. 01, 2011
Pall Corporation [Member]
Aug. 01, 2012
Pall Corporation [Member]
Aug. 01, 2012
Acquired Technology [Member]
Pall Corporation [Member]
Aug. 01, 2012
Customer Relationships [Member]
Pall Corporation [Member]
Aug. 01, 2012
Acquired Technology and Customer Relationships [Member]
Pall Corporation [Member]
Y
Sep. 29, 2012
Acquired Technology and Customer Relationships [Member]
Pall Corporation [Member]
Business Acquisition [Line Items]                        
Business acquistion, cost of aquired entity               $ 535,100,000        
Business acquisition, additional anticipated payment               15,000,000        
Face amount of debt               475,000,000        
Asset class                        
Inventories               52,421,000        
Property, plant and equipment               70,709,000        
Intangible assets               206,750,000 144,800,000 62,000,000    
Other assets               184,000        
Liabilities               (1,986,000)        
Goodwill               207,066,000        
Fair value of net assets acquired               535,144,000        
Estimated useful life                     10  
Amortization expense                       3,500,000
Transaction costs         700,000 2,800,000            
Revenue         28,600,000              
Reduction to net income         3,500,000              
Cost of goods sold 116,416,000 89,496,000 202,778,000 171,316,000 8,300,000              
Net sales           466,586,000 457,914,000          
Net income           27,410,000 26,946,000          
Basic earnigs per share (in dollars per share)           $ 0 $ 0          
Diluted earnigs per share (in dollars per share)           $ 0 $ 0          
Transaction costs         2,786,000 [1] 2,786,000 [1] 0 [1]          
Amortization of inventory fair value adjustment         8,300,000 [2] 8,300,000 [2] (11,067,000) [2]          
Amortization of acquired intangible assets         (6,892,000) [3] (6,892,000) [3] (10,338,000) [3]          
Interest expense incurred on acquisition financing         (3,173,000) [4] (3,173,000) [4] (4,760,000) [4]          
Selling, general and admin expenses         (3,513,000) [5] (3,513,000) [5] (5,270,000) [5]          
Amount of transaction prior to acquisition               $ 10,000,000        
[1] Eliminated transactions costs as these non-recurring costs were incurred in the first and second quarter of FY 13
[2] Added additional expense in the period ended October 1, 2011 to reflect the inventory fair value adjustments which would have been amortized had the transaction been consummated on April 3, 2011 as the corresponding inventory would have been completely sold during the first two quarters of 2011 and deducted the actual inventory fair value adjustment recorded in the six months ended September 2012 to reflect the pro-forma consumption of inventory in 2011
[3] Added additional amortization of the acquired whole blood intangible assets recognized at fair value in purchase accounting
[4] Added additional interest expense for the debt used to finance the acquisition.
[5] Additional investments in infrastructure costs to replicate certain support functions performed by division or corporate organizations of Pall that did not transfer in the acquisition. These costs are primarily related to information technology infrastructure and application costs, and personnel costs required to expand regional and corporate administrative and sales support functions. These costs are not intended to be representative of actual costs incurred by Pall Corporation, and represent Haemonetics best estimate of future incremental costs on an annualized basis. Actual incremental investments may differ from these estimates